LBCA’s Scientific Advisory Board members have co-authored 10 new ILC specific studies so far this year. See the links below to read more about each online.
SAB Members Dr. Rinath Jeselsohn and Dr. Rita Mukhtar co-authored an article:
SAB Member Dr. Rita Mukhtar co-authored multiple articles including:
- A prospective single-arm pilot study evaluating [F-18]fluoroestradiol dedicated breast PET in invasive lobular carcinoma after neoadjuvant endocrine therapy
- Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue
- Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status in European Journal of Cancer
- Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancer
- Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
- Preclinical models of breast cancer metastasis: strengths, limitations, and clinical relevance
- LOX Inhibition Disrupts a Collagen-Integrin–MYC Axis to Suppress Progression of Invasive Lobular Carcinoma